Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Novo Nordisk Q2 2024 GAAP EPS DKK 4.49 Misses DKK 5.05 Estimate, Sales DKK 68.060B Miss DKK 68.654B Estimate

Author: Benzinga Newsdesk | August 07, 2024 02:45am
Novo Nordisk (NYSE:NVO) reported quarterly earnings of $4.49 per share which missed the analyst consensus estimate of $5.05 by 11.09 percent. This is a 3.94 percent increase over earnings of $4.32 per share from the same period last year. The company reported quarterly sales of $68.060 billion which missed the analyst consensus estimate of $68.654 billion by 0.87 percent. This is a 25.34 percent increase over sales of $54.300 billion the same period last year.

Posted In: NVO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist